Metric Finance
LearnFAQ
LearnFAQ

Learn / INNV

NASDAQ: INNV

InnovAge Holding (INNV) stock, explained like you're 5

InnovAge Holding trades on the Nasdaq under the ticker INNV. It is a small cap company in the medical/nursing services industry, part of the healthcare sector, with a market value of about 1.2 billion dollars.

Ticker
INNV
Exchange
Nasdaq
Sector
Healthcare
Industry
Medical/Nursing Services
Size
Small cap, about 1.2 billion dollars

Is InnovAge Holding a small, medium or large cap company?

No. InnovAge Holding is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.2 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How InnovAge Holding makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves INNV stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • InnovAge (NASDAQ:INNV) Stock Rating Cut to "Buy" at Wall Street Zen (MarketBeat)
  • (INNV) Movement as an Input in Quant Signal Sets (Stock Traders Daily)
  • InnovAge Holding (INNV), Why Is It Getting Fresh Attention? (Yahoo Finance)
  • A $292,581 share sale is proposed by InnovAge (NASDAQ: INNV) affiliate Nicole Damato. (Stock Titan)
  • InnovAge (INNV) Shares Tumble 9% After Hours: Here's Why (Benzinga)

Follow INNV in your daily brief

Each trading day at 5 PM ET we post what happened to InnovAge Holding and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow INNV

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about InnovAge Holding stock

What does InnovAge Holding do?

InnovAge Holding trades on the Nasdaq under the ticker INNV. It is a small cap company in the medical/nursing services industry, part of the healthcare sector, with a market value of about 1.2 billion dollars.

What is the ticker symbol for InnovAge Holding?

InnovAge Holding trades under the ticker INNV on the Nasdaq.

What is InnovAge Holding's market cap?

InnovAge Holding is a small cap stock with a market cap of about 1.2 billion dollars.

How does InnovAge Holding make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves INNV stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow INNV stock every day?

Add INNV to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow INNV daily

A free brief on InnovAge Holding and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • BTSGU · BrightSpring Health Services
  • BTSG · BrightSpring Health Services
  • HIMS · Hims & Hers Health
  • CHE · Chemed

Similar stocks

  • BTSGUBrightSpring Health Services
  • BTSGBrightSpring Health Services
  • HIMSHims & Hers Health
  • CHEChemed

Compare INNV: INNV vs BTSGU, INNV vs BTSG, INNV vs HIMS

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed